SCHEMBL22573501

SCHEMBL22573501

Cc1ccnc(NC(=O)c2cnc(-c3ccco3)nc2N)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.60
▸ ADORA2A P29274 2/20 0.60
▸ ADORA2B P29275 2/20 0.60
▸ ADORA1 P30542 2/20 0.60
▸ NPC1 O15118 11/20 0.54
▸ RAB9A P51151 11/20 0.54
▸ SMN1; SMN2 Q16637 6/20 0.54
▸ PKM P14618 2/20 0.54
▸ HSD17B10 Q99714 1/20 0.52
▸ KMT2A Q03164 5/20 0.51
▸ POLB P06746 1/20 0.51
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ MEN1 O00255 3/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573626 0.86 ADORA3 (0.58) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL22573343 0.85 TSHR (0.58) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL22573464 0.85 ADORA2A (0.57) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL22573335 0.84 ADORA2A (0.59) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL22573604 0.84 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL22574016 0.83 ADORA3 (0.58) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL22573408 0.83 ADORA3 (0.60) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL22573804 0.83 ATM (0.58) NPC1RAB9ASMN1; SMN2PKMKMT2A
SCHEMBL22573552 0.81 ADORA2A (0.66) ADORA3ADORA2AADORA2BADORA1HSD17B10
SCHEMBL22573609 0.81 ADORA2A (0.66) ADORA3ADORA2AADORA2BADORA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback